- Home
- CMCO vs ORGO Comparison
CMCO vs ORGO Comparison
Compare CMCO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCO | ORGO |
|---|---|---|
| Founded | 1875 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.4M | 348.6M |
| IPO Year | 2002 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CMCO | ORGO |
|---|---|---|
| Price | $14.30 | $2.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $21.00 | $8.50 |
| AVG Volume (30 Days) | 223.2K | ★ 1.3M |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $936,240,000.00 | $564,169,000.00 |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $82.91 | $26.27 |
| P/E Ratio | $47.57 | ★ N/A |
| Revenue Growth | 3.27 | ★ 17.04 |
| 52 Week Low | $13.31 | $2.04 |
| 52 Week High | $24.40 | $7.08 |
Technical Indicators
Market Signals| Indicator | CMCO | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 52.46 |
| Support Level | $13.89 | $2.21 |
| Resistance Level | $15.49 | $2.63 |
| Average True Range (ATR) | 0.58 | 0.21 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 30.57 | 68.46 |
Price Performance
Historical ComparisonAbout CMCO Columbus McKinnon Corporation
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.